» Articles » PMID: 16293602

The Polycomb Group Gene Ezh2 Prevents Hematopoietic Stem Cell Exhaustion

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2005 Nov 19
PMID 16293602
Citations 178
Authors
Affiliations
Soon will be listed here.
Abstract

The molecular mechanism responsible for a decline of stem cell functioning after replicative stress remains unknown. We used mouse embryonic fibroblasts (MEFs) and hematopoietic stem cells (HSCs) to identify genes involved in the process of cellular aging. In proliferating and senescent MEFs one of the most differentially expressed transcripts was Enhancer of zeste homolog 2 (Ezh2), a Polycomb group protein (PcG) involved in histone methylation and deacetylation. Retroviral overexpression of Ezh2 in MEFs resulted in bypassing of the senescence program. More importantly, whereas normal HSCs were rapidly exhausted after serial transplantations, overexpression of Ezh2 completely conserved long-term repopulating potential. Animals that were reconstituted with 3 times serially transplanted control bone marrow cells all died due to hematopoietic failure. In contrast, similarly transplanted Ezh2-overexpressing stem cells restored stem cell quality to normal levels. In a "genetic genomics" screen, we identified novel putative Ezh2 target or partner stem cell genes that are associated with chromatin modification. Our data suggest that stabilization of the chromatin structure preserves HSC potential after replicative stress.

Citing Articles

Computational exploration in search for novel natural product-derived EZH2 inhibitors for advancing anti-cancer therapy.

Shyamal S Mol Divers. 2025; .

PMID: 39969739 DOI: 10.1007/s11030-025-11128-3.


The epigenetic role of EZH2 in acute myeloid leukemia.

Fang J, Zhang J, Zhu L, Xin X, Hu H PeerJ. 2024; 12:e18656.

PMID: 39655332 PMC: 11627098. DOI: 10.7717/peerj.18656.


Developmental Stage and Cellular Context Determine Oncogenic and Molecular Outcomes of Mutation in Hematopoiesis.

Zimmerman S, Procasky S, Smith S, Liu J, Torrice C, Souroullas G bioRxiv. 2024; .

PMID: 39605688 PMC: 11601384. DOI: 10.1101/2024.11.14.622807.


Targeting heterochromatin eliminates chronic myelomonocytic leukemia malignant stem cells through reactivation of retroelements and immune pathways.

Hidaoui D, Porquet A, Chelbi R, Bohm M, Polyzou A, Alcazer V Commun Biol. 2024; 7(1):1555.

PMID: 39578583 PMC: 11584673. DOI: 10.1038/s42003-024-07214-1.


Cellular stress and epigenetic regulation in adult stem cells.

Llewellyn J, Baratam R, Culig L, Beerman I Life Sci Alliance. 2024; 7(12).

PMID: 39348938 PMC: 11443024. DOI: 10.26508/lsa.202302083.


References
1.
Trevisan M, Iscove N . Phenotypic analysis of murine long-term hemopoietic reconstituting cells quantitated competitively in vivo and comparison with more advanced colony-forming progeny. J Exp Med. 1995; 181(1):93-103. PMC: 2191852. DOI: 10.1084/jem.181.1.93. View

2.
de Haan G, Bystrykh L, Weersing E, Dontje B, Geiger H, Ivanova N . A genetic and genomic analysis identifies a cluster of genes associated with hematopoietic cell turnover. Blood. 2002; 100(6):2056-62. DOI: 10.1182/blood-2002-03-0808. View

3.
Pirrotta V . Chromatin complexes regulating gene expression in Drosophila. Curr Opin Genet Dev. 1995; 5(4):466-72. DOI: 10.1016/0959-437x(95)90050-q. View

4.
Morrison S, Uchida N, Weissman I . The biology of hematopoietic stem cells. Annu Rev Cell Dev Biol. 1995; 11:35-71. DOI: 10.1146/annurev.cb.11.110195.000343. View

5.
Morrison S, Wandycz A, Akashi K, Globerson A, Weissman I . The aging of hematopoietic stem cells. Nat Med. 1996; 2(9):1011-6. DOI: 10.1038/nm0996-1011. View